DNTH
Price
$16.95
Change
-$0.91 (-5.10%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
573.76M
LRMR
Price
$1.97
Change
-$0.23 (-10.45%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
140.86M
35 days until earnings call
Ad is loading...

DNTH vs LRMR

Header iconDNTH vs LRMR Comparison
Open Charts DNTH vs LRMRBanner chart's image
Dianthus Therapeutics
Price$16.95
Change-$0.91 (-5.10%)
Volume$13.52K
Capitalization573.76M
Larimar Therapeutics
Price$1.97
Change-$0.23 (-10.45%)
Volume$8.04K
Capitalization140.86M
DNTH vs LRMR Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. LRMR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and LRMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DNTH: $17.86 vs. LRMR: $2.20)
Brand notoriety: DNTH and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 317% vs. LRMR: 214%
Market capitalization -- DNTH: $545.16M vs. LRMR: $126.13M
DNTH [@Biotechnology] is valued at $545.16M. LRMR’s [@Biotechnology] market capitalization is $126.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 6 bearish.
  • LRMR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а -2.24% price change this week, while LRMR (@Biotechnology) price change was -2.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 09, 2023.

LRMR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($574M) has a higher market cap than LRMR($141M). DNTH YTD gains are higher at: -18.073 vs. LRMR (-43.152). LRMR has higher annual earnings (EBITDA): -73.44M vs. DNTH (-101.45M). DNTH has more cash in the bank: 275M vs. LRMR (204M). DNTH has less debt than LRMR: DNTH (1.49M) vs LRMR (5.36M). DNTH has higher revenues than LRMR: DNTH (6.24M) vs LRMR (0).
DNTHLRMRDNTH / LRMR
Capitalization574M141M407%
EBITDA-101.45M-73.44M138%
Gain YTD-18.073-43.15242%
P/E Ratio3.24N/A-
Revenue6.24M0-
Total Cash275M204M135%
Total Debt1.49M5.36M28%
FUNDAMENTALS RATINGS
DNTH vs LRMR: Fundamental Ratings
DNTH
LRMR
OUTLOOK RATING
1..100
8367
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
8996
P/E GROWTH RATING
1..100
61100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is somewhat better than the same rating for DNTH (55). This means that LRMR’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (59) in the null industry is somewhat better than the same rating for LRMR (100). This means that DNTH’s stock grew somewhat faster than LRMR’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as LRMR (100). This means that DNTH’s stock grew similarly to LRMR’s over the last 12 months.

DNTH's Price Growth Rating (89) in the null industry is in the same range as LRMR (96). This means that DNTH’s stock grew similarly to LRMR’s over the last 12 months.

DNTH's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for LRMR (100). This means that DNTH’s stock grew somewhat faster than LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHLRMR
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend about 1 month ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCBX38.920.31
+0.80%
MFS Technology B
MAIPX15.070.04
+0.27%
MAI Managed Volatility Institutional
OASGX10.27N/A
N/A
Optimum Small-Mid Cap Growth A
PEIQX39.10N/A
N/A
Principal Equity Income R5
CMPCX19.26N/A
N/A
Calvert Small/Mid-Cap C

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMVT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+6.12%
IMVT - DNTH
43%
Loosely correlated
+8.03%
IMNM - DNTH
42%
Loosely correlated
+7.19%
COGT - DNTH
40%
Loosely correlated
-1.21%
PRME - DNTH
40%
Loosely correlated
+0.28%
LRMR - DNTH
40%
Loosely correlated
+10.00%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+10.00%
SVRA - LRMR
45%
Loosely correlated
+5.24%
ACLX - LRMR
42%
Loosely correlated
+10.76%
IMNM - LRMR
41%
Loosely correlated
+7.19%
ERAS - LRMR
41%
Loosely correlated
+4.56%
IDYA - LRMR
41%
Loosely correlated
+10.70%
More